OBJECTIVE. The purpose of our study was to evaluate the clinical feasibility and usefulness of a 2D spoiled gradient-recalled echo MR sequence with serial switching of reversed centric and centric k-space reordering for high-spatial-resolution gadolinium-enhanced double hepatic arterial phase (HAP) MRI of the liver.
n recent years, the rapid scanning capability of MDCT has enabled multiple scanning of the entire liver in a single hepatic arterial dominant phase of IV contrast-enhanced CT. With this technique, radiologists can observe hemodynamics in focal hepatic lesions and differentiate hypervascular hepatocellular carcinoma (HCC) from benign tumors and pseudolesions [1] . Meanwhile, a substantial incremental gain in imaging speed has been achieved with the development of MRI parallel acquisition [2] [3] [4] . This technique has been applied to liver MRI to enable double hepatic arterial phase (HAP) imaging of the liver after IV bolus injection of a gadolinium chelate [5] .
However, in double HAP imaging of the liver during a single breath-hold, the numbers of imaging matrices and obtainable slices must be reduced, even with the parallel acquisition technique, because of the intrinsic trade-off with MRI parameters. We needed an MRI sequence that maintained high spatial resolution while enabling capture of efficient double HAP contrast with the use of sophisticated k-space reordering strategies [6] . We thus performed whole-liver MRI with a 2D highspatial-resolution gadolinium-enhanced double HAP gradient-recalled echo sequence with serial switching and reversed centric and centric k-space reordering. This technique enables acquisition of 30 6-mm-thick slices I covering the entire liver at a frequency of 512 and phase-encoding of 224 during an 18-second breath-hold. It also allows capture of early and late HAPs with an interval of 11 seconds. This study was a preliminary evaluation of the clinical feasibility and usefulness of double HAP MRI of the liver.
Subjects and Methods Patients
During the 3-month period from June to August 2003, 102 consecutive patients with signs and symptoms of liver disease underwent gadoliniumenhanced MRI of the liver in our department. These patients had previously undergone sonography, CT, or laboratory evaluations. All patients were informed that the radiologic examinations were primarily for clinical diagnosis and secondarily for radiologic research. Thereafter, they all signed waivers in conformity with the requirements of our institutional review board.
These 102 patients, 75 men and 27 women (age range, 29-83 years; mean, 67.1 years), formed the study population. Forty-one of the 102 patients had HCC with chronic hepatitis or cirrhosis, 24 had cirrhosis, 10 had chronic hepatitis, five had metastatic lesions, three had cavernous hemangioma, one had HCC without chronic hepatitis or cirrhosis, one had cholangiocellular carcinoma, one had diffuse fatty liver, one had an inflammatory myofibroblastic tumor, one had biliary hamartomatosis, and 14 had a healthy liver.
MRI Protocol
MRI was performed with a 1.5-T superconducting MR system (Signa Excite Xl TwinSpeed 1.5 T, GE Healthcare Technologies). The system provided a maximum gradient strength of 23 mT/m, with a peak slew rate of 80 mT/m/ms for the whole-body mode used in this study. All MR images were obtained in a transaxial plane with an eight-channel phased-array multicoil and a field of view of 38 cm. The MRI protocol consisted of dual-phase T1-weighted spoiled gradient-recalled echo images (TR/TE, 245/4.2 in phase; 245/2.2 opposed phase; 320 × 224 frequency × phase encoding matrix; receiver bandwidth of ± 125 kHz; parallel imaging reduction factor of 2; one signal acquired; and 27-second breath-hold acquisitions for 30 slices per breath-hold), fat-suppressed respiration-triggered fast spin-echo T2-weighted images (TR/effective TE, 7,500-9,200/80.6-88.6, echo-train length of 12-18, 512 × 256 matrix, receiver bandwidth of ± 62.5 kHz, reduction factor of 2, 2 signals acquired, 3-to 4-minute acquisition time), and breathhold gadolinium-enhanced double HAP spoiled gradient-recalled echo images (155/1.5, 60° flip angle, 512 × 224 matrix without interpolation, 6-mm slice thickness with 1-mm intersection gap, receiver bandwidth of ± 62.5 kHz, reduction factor of 2, one signal acquired, 30 slices per 18 seconds).
Test Bolus Imaging
Test bolus imaging was performed to determine the aortic transit time, defined as the time from ini- Fig. 1 -Drawing shows timing scheme of double hepatic arterial phase (HAP) imaging. K-space lines for early HAP imaging are filled with echo data from k-space margins to center, and those for other phase imaging are filled from center to margins. Eight dummy excitation pulses are given for first second. K-space centers are filled 10, 21, 49, and 181 seconds after arrival of contrast medium in abdominal aorta. Practical imaging delay (D) for early HAP imaging is determined as follows: D = T V-A -8, where T V-A is aortic transit time in test bolus imaging. Eight seconds is subtracted so that end of first HAP imaging (k-space center) comes 10 seconds after arrival of contrast medium in abdominal aorta. Late HAP imaging begins automatically after 10-second breathing interval after early HAP imaging. Portal venous phase imaging is started 10 seconds after late HAP imaging. Equilibrium phase imaging is initiated so that k-space lines are filled at 181 seconds. tiation of IV injection of contrast material to peak enhancement in the abdominal aorta at the level of the first lumbar vertebral body. Coronal single-section spoiled gradient-recalled echo images (14.7/1.8, 30° flip angle, 256 × 128 matrix, receiver bandwidth of ± 31.3 kHz, 1 signal acquired, 1-second acquisition time) were obtained every second after initiation of an IV bolus injection of 1 mL of gadopentetate dimeglumine (Magnevist, Schering) followed by a flush with a sterile saline solution. The volume of the flush was calculated from patient body weight according to the following equation:
where V is the volume of saline solution in milliliters and W body is patient body weight in kilograms. A power injector (Sonic Shot 50, Nemotokyorindo) was used to inject first contrast material and then the saline solution into an antecubital vein through a 22-gauge 25-mm-long catheter at a rate of 3 mL/s. Radiology technicians using a circular cursor 15 mm in diameter obtained operator-defined regionof-interest measurements of the mean signal intensity of the abdominal aorta on test bolus gradientrecalled echo images. Aortic transit time in seconds was determined as the time from initiation of contrast injection to peak enhancement.
Double HAP MRI of the Liver
Breath-hold double HAP MRI of the liver was performed with a field of view of 38 cm. MR images were obtained before and after IV bolus injection of 0.1 mmol of gadopentetate dimeglumine per kilogram of body weight followed by a 15-mL flush of sterile saline solution. The amount of sterile saline solution flushed was fixed in all patients. The power injector used for test bolus imaging was also used for injecting contrast material and saline solution at a rate of 3 mL/s. Figure 1 illustrates a double HAP MRI timing scheme. The k-space lines in the phase-encoding direction for early HAP imaging were filled with the center of k-space performed at the end of scan acquisition (reversed centric reordering). The next and subsequent acquisitions were performed with the center of k-space acquired at the beginning of the sequences (centric reordering). Eight dummy excitation pulses of approximately 1 second were given at the start of each sequence. The center of the k-space lines was filled 10, 21, 49, and 181 seconds after the arrival of the contrast medium in the abdominal aorta. The practical imaging delay (D, the time in seconds from initiation of contrast injection to initiation of gradient-recalled echo image acquisition) for early HAP imaging was determined in individual patients by use of the following equation:
where T V-A is aortic transit time (from the antecubital vein [V] to the abdominal aorta [A]) determined by means of test bolus imaging. Eight seconds was subtracted from T V-A so that the end of the first HAP imaging data acquisition occurred 10 seconds after arrival of the contrast medium in the abdominal aorta, because the central k-space lines determined the bulk of signal intensity on MR images. Late HAP imaging was begun automatically after a 10-second breathing interval after completion of early HAP imaging such that k-space lines were filled 21 seconds after arrival of the contrast medium in the abdominal aorta. Likewise, portal venous phase imaging with centric k-space filling was started 10 seconds after the end of late HAP imaging such that k-space lines were filled at 49 seconds. An equilibrium phase gradient-recalled echo sequence with centric k-space filling was initiated 180 seconds after the initiation of contrast injection such that k-space lines were filled at 181 seconds.
Quantitative Image Analysis
One radiologist obtained quantitative measurements on the images of 97 patients. The quality of the images of three of the five excluded patients was substantially impaired by motion artifacts, and the other two patients had advanced multiple liver tumors. Operator-defined region-of-interest measurements were obtained on unenhanced, early HAP, late HAP, portal venous phase, and equilibrium phase images. Mean signal intensity was measured in the abdominal aorta, spleen, portal trunk, right and left lobes of the liver, and hepatic veins. A circular cursor 5-40 mm in diameter was used to measure the signal intensity of anatomic structures. Signal intensity in the liver and spleen was measured in regions without large vessels, dilated intrahepatic biliary ducts, or prominent artifacts. Because of the near-field effect of the surface coil, cursors were placed so that slice level and distance from the abdominal walls were consistent for the different imaging sequences. In each patient, two hepatic parenchymal (right and left lobes) and two hepatic venous (right or middle hepatic and left hepatic veins) measurements were averaged to obtain the mean signal intensity for even sampling of signal intensity in the liver. Spleen-to-liver contrast was calculated by subtracting the mean signal intensity of the liver from that of the spleen.
In 48 untreated hypervascular HCC nodules ranging in size from 8 to 83 mm (mean, 22 mm) in 35 patients who were 48-83 years old (mean, 71 years), signal intensity was measured in the HCC and in the surrounding liver. Proof of HCC was obtained with percutaneous liver biopsy (n = 15) or a substantially increased α-fetoprotein level or level of protein induced by vitamin K absence or antagonism (PIVKA) II in combination with follow-up CT or MRI showing tumor progression (n = 33). Tumor-to-liver contrast was calculated by subtracting the mean signal intensity of an HCC from that of the surrounding liver.
Qualitative Image Analysis
Two gastrointestinal radiologists independently reviewed the early HAP, late HAP, portal venous phase, and equilibrium phase images with reference to the unenhanced images and then reached consensus by discussion. The images were evaluated on a radiologic viewer by means of subjective assessment by the reviewers, who were blinded to patient clinical information.
We defined the characteristics of early HAP as spleen intensely enhanced, proximal portal veins and liver parenchyma not or minimally enhanced, and hepatic veins not enhanced; of late HAP as spleen intensely enhanced, proximal portal veins and liver parenchyma minimally to moderately enhanced, and hepatic veins not or minimally enhanced; of the portal venous phase as liver parenchyma enhanced as intensely as the spleen; and of the equilibrium phase as all vessels weakly enhanced to the same degree. On the basis of these definitions, the reviewers recorded their impression for the overall image value of each contrast phase as good, fair, or poor. The reviewers also recorded the pertinence of scan timing for each contrast phase as premature, optimal, or lagged. Finally, the reviewers assessed overall image degradation due to artifacts (i.e., motion, susceptibility, or blurring) as none, mild, moderate, or severe. "Severe" was assigned when the image interpretation was hampered because of image degradation.
For the 48 untreated hypervascular HCC nodules, the reviewers used a seven-point scale to evaluate the degree of hepatic arterial enhancement or washout of HCC in each phase. A score of 3 was assigned for intense enhancement, 2 for moderate enhancement, 1 for mild enhancement, 0 for no enhancement or washout, -1 for mild washout, -2 for moderate washout, and -3 for distinct washout.
Statistical Analysis
Repeated measures analysis of variance and multiple comparisons with the Scheffé criterion [7] were performed to assess the transition of mean signal intensities in the abdominal aorta, spleen, portal trunk, liver parenchyma, and hepatic veins and spleen-to-liver and tumor-to-liver contrast. The Kruskal-Wallis test and multiple comparisons with the Scheffé criterion were performed for evaluation of qualitative degrees obtained as categoric data. Interobserver variability was assessed with the kappa test. A kappa value up to 0.20 showed slight agreement, a value of 0.21-0.40 showed fair agreement, 0.41-0.60 showed moderate agreement, 0.61-0.80 showed substantial agreement, and 0.81 or greater showed almost perfect agreement.
Results
The signal intensity of the abdominal aorta peaked in the early HAP and then decreased over time. The signal intensity of the spleen was high in the early HAP, late HAP, and portal venous phase and decreased slightly in the equilibrium phase (Fig. 2) . The signal intensity of the portal trunk increased steeply over the late HAP and decreased gradually. The signal intensity of liver parenchyma constantly increased over the portal venous phase and then decreased slightly in the equilibrium phase. The signal intensity of hepatic veins increased steeply over the portal venous phase and then decreased slightly in the equilibrium phase (Fig. 3) . Spleen-to-liver contrast peaked in the early HAP and then decreased steadily with time. Tumor-to-liver contrast peaked in the early HAP and then constantly decreased with time and was negative during the portal venous and equilibrium phases (Fig. 4) .
The value of early or late HAP images was good or fair in most patients ( Table 1 ). The scan timing of early HAP and late HAP was optimal in 74 (73%) of the 102 patients, of late HAP lagged in 20 (20%), of early HAP was premature in six (6%), and of early HAP lagged in five (5%) of the patients. Scan timing for the portal venous phase and the equilibrium phase was optimal in all patients (Table 2) . Sufficient image quality for image interpretation was achieved in 99 (97%) of the patients (Figs. 5 and 6) . One of the other three patients had motion artifacts due to body motion, and two had unsatisfactory respiratory suspension ( Table 3) .
The qualitative results corresponded well to the quantitative results shown in Figure 4 . In three (9%) of the 35 patients with HCC, tumors not depicted in the early HAP because of premature scan timing were well depicted as hypervascular lesions in the late HAP (Fig. 7) . Kappa values for the two reviewers who performed the independent rating of images were found to range from 0.71 to 1.00 (mean, 0.80), indicating substantial to almost complete agreement.
Discussion
Double HAP contrast-enhanced CT, which allows acquisition of both early and late arterial hepatic images, reveals hemodynamic Signal intensity of abdominal aorta peaks in early hepatic arterial phase (HAP) and then decreases over time. Significant differences in mean signal intensity (p < 0.005) exist between all phases but not between late HAP and portal venous phase (PVP). Signal intensity of spleen is high in early HAP, late HAP, and portal venous phase and then decreases slightly in equilibrium phase (EP). Significant differences in mean signal intensity (p < 0.0001) exist between all phases but not between early HAP and equilibrium phase or between late HAP and portal venous phase. Pre = before contrast injection. Fig. 3 -Graph shows contrast phase versus mean signal intensity for portal trunk, liver parenchyma, and hepatic veins. Signal intensity of portal trunk increases steeply over late hepatic arterial phase (HAP) and then decreases gradually. Significant differences in mean signal intensity (p < 0.05) exist between all phases but not between late HAP and portal venous phase (PVP). Signal intensity of liver parenchyma increases constantly over portal venous phase and then decreases slightly in equilibrium phase (EP). Significant differences in mean signal intensity (p < 0.05) exist between all phases but not between late HAP and equilibrium phase or between portal venous and equilibrium phases. Signal intensity of hepatic veins increases steeply over portal venous phase and then decreases slightly in equilibrium phase. Significant differences in mean signal intensity exist between all phases (p < 0.005). Pre = before contrast injection. Moreover, interpretation of images obtained during both arterial phases has shown that findings on images in these phases have the greatest sensitivity and positive predictive value [1] . MRI offers information on T1 and T2 relaxation times with unenhanced MR images, on fat deposition with phase-shift gradient-recalled echo images, and on hemodynamics with double HAP imaging. There are, however, intrinsic trade-offs in MRI with respect to imaging matrices and number of obtainable slices that apply to our double HAP sequence. Our MRI sequence maintained large imaging matrices of 512 frequency and 224 phase encoding without zero-fill interpolation and allowed acquisition of 30 6-mmthick images by extending the acquisition time for a single phase to 18 seconds. The rationale behind this imaging sequence was that it enables capture of double HAP contrast over a 10-second breathing interval by switching the direction of k-space reordering from reversed centric to centric filling during the early and late HAPs. The series of scan times we set for multiphase imaging was optimal in most patients in our study. Scan timing for the early HAP was premature in 6% of the patients, although we used test bolus imaging before liver imaging in all patients. Even in such cases, late HAP imaging was helpful in the detection of hypervascular HCCs that were missed in the early HAP. We may, however, need to push the scan timing of the late HAP ahead somewhat because it lagged in 20% of the patients in our study. Regarding image quality, the spoiled gradient-recalled echo sequence we used was robust for the use of double HAP imaging, as the qualitative assessment of image degradation indicated.
Some researchers have reported on the usefulness of the 3D gradient-recalled echo se- quence in gadolinium-enhanced MRI of the liver [8] , although few reports on the application of a 3D gradient-recalled echo sequence for double HAP imaging are available. Although a 3D sequence was initially developed for use in gadolinium-enhanced MR angiography, this sequence has been widely applied to contrast-enhanced MRI of the liver. Our present technique with a 2D sequence may apply for double HAP imaging with a 3D sequence. Ueda et al. [9] , who investigated the hemodynamics of hypervascular HCC with singlelevel dynamic CT during hepatic arteriography, reported that whole HCC enhancement and clear contour visualization began 4.5 seconds after the start of hepatic arterial contrast injection; contrast enhancement in the adjacent liver began at 10.5 seconds; and the contrast material was washed out from the tumor and coronal enhancement of adjacent liver appeared at 22.4 seconds. On the basis of their results, we set a breathing interval between the early and late HAPs such that the filling of each central kspace occurred at intervals of 11 seconds. Eight-channel coil technology contributed to the efficiency of our sequence. Multichannel phased-array coils offer increased signalto-noise ratio over standard coils near the array elements while preserving signal-to-noise ratio at the center of the object [10, 11] . Despite the use of large imaging matrices, a thin slice, and the parallel acquisition technique, we were able to maintain sufficient image contrast with our sequence because of the improved signal-to-noise capability of eightchannel phased-array coils.
Regarding reduction factor number for the parallel imaging technique, image acquisition accelerated by a factor of 2-3 is common for many clinical applications [12] . We used a reduction factor of 2 for our sequence. Although this number could have been set greater than 2 to further shorten the acquisition time, reduced signal-to-noise ratio and increased risk of wrap-around artifact became problematic in a preliminary evaluation.
There are possible drawbacks to the double HAP sequence. First, image sharpness of the first HAP images might have been impaired because both top and bottom peripheral k-space lines filled before sufficient contrast material had reached the liver or tumors. Nevertheless, there was no significant image blurring, and hypervascular HCCs were well depicted on the first HAP images. We infer that this blurring did not affect clinical image interpretation. Second, slice levels might have been staggered on the early and late HAP images because there was an in-between breathing interval. This drawback was compensated by the thin slices used.
There were limitations to our study. First, there was lack of pathologic standard of reference in many cases, and we did not assess observer performance in terms of the diagnosis of focal liver lesions. The real effect of the sequence on clinical radiologic practice should be clarified by results of future biostatistical studies. Although we set an interval of 11 seconds between the central k-space Note-Numbers in parentheses are percentages. Finally, because we used the parallel imaging technique, we could not normalize signal-to-noise and contrast-to-noise ratios using SDs of the signal intensities of background, which were measured in the phaseencoding direction outside the anterior abdominal wall. Instead, we used mean signal intensity measured by the region-of-interest method to assess transition of degree of contrast enhancement over multiphase imaging. We assumed that background noise was constant throughout the multiple contrast phases.
In conclusion, in whole-liver imaging we used a 2D gadolinium-enhanced double HAP spoiled gradient-recalled echo imaging sequence incorporating serial switching of reversed centric and centric k-space reordering. This technique has the potential for use as a high-spatial-resolution gadolinium-enhanced double HAP MRI sequence for the diagnosis of hypervascular HCC.
